R

Remus Pharmaceuticals Limited

NSE-REMUS
National Stock Exchange of India
Drugs, Drug Proprietaries, and Druggists' Sundries
Global Rank
#23022
Country Rank
#1390
Market Cap
$131.94 M
Price
$11.2
Change (%)
7.33%
Volume
12,500

Remus Pharmaceuticals Limited's latest marketcap:

$131.94 M

As of 07/25/2025, Remus Pharmaceuticals Limited's market capitalization has reached $131.94 M. According to our data, Remus Pharmaceuticals Limited is the 23022th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap $131.94 M
Revenue (ttm) $71.74 M
Net Income (ttm) $3.36 M
Shares Out 11.78 M
EPS (ttm) $0.38
Forward PE 0.00
Ex-Dividend Date 11/19/2024
Earnings Date 08/08/2025
Market Cap Chart
Data Updated: 07/25/2025

Remus Pharmaceuticals Limited's yearly market capitalization.

Remus Pharmaceuticals Limited has seen its market value grow from ₹11.27 B to ₹11.41 B since 2023, representing a total increase of 1.20% and an annual compound growth rate (CAGR) of 0.76%.
Date Market Cap(₹) Market Cap(USD) Change (%) Global Rank
07/25/2025 ₹11.41 B $131.94 M -22.47% 23022
12/31/2024 ₹14.72 B $171.9 M 30.53% 19912
12/29/2023 ₹11.27 B $135.51 M 21163

Company Profile

About Remus Pharmaceuticals Limited

Remus Pharmaceuticals Limited is a pharmaceutical company specializing in the marketing, trading, and distribution of finished formulations and products across India and international markets.

Core Business Activities

  • Marketing and distribution of pharmaceutical formulations.
  • Trading of active pharmaceutical ingredients (APIs).
  • Providing technical consultancy services to distributors.
  • Offering contract manufacturing services.

Product Portfolio

The company offers a diverse range of pharmaceutical products, including:

  • Capsules, creams, and gels
  • Eye drops, infusions, and inhalations
  • Injections, nasal sprays, and nebulizers
  • Ointments, ophthalmic solutions, and oral suspensions
  • Sachets, tablets, and more

Global Presence

Remus Pharmaceuticals operates in multiple countries, including:

  • Bhutan, Bolivia, Chile, and Costa Rica
  • Cuba, Dominican Republic, Ecuador, and El Salvador
  • Guatemala, Honduras, Jamaica, and Kuwait
  • Madagascar, Malaysia, Hong Kong, and Myanmar
  • Panama, Trinidad and Tobago, Uzbekistan, Venezuela, and Vietnam

Company Background

Originally incorporated in 2015 as Remus Pharmaceuticals Private Limited, the company rebranded to Remus Pharmaceuticals Limited in January 2023. It is headquartered in Ahmedabad, India.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.